BIOMARIN PHARMACEUTICAL INC (BMRN) › Net IncomeBIOMARIN PHARMACEUTICAL INC (BMRN) — Net IncomeAnnual figures by fiscal year, from SEC filings.2008: $30.83M2009: -$488.0K2010: $205.82M2011: -$53.84M2012: -$114.35M2013: -$176.35M2014: -$133.97M2015: -$171.80M2016: -$630.21M2017: -$117.04M2018: -$77.21M2019: -$23.85M2020: $854.03M2021: -$64.08M2022: $141.56M2023: $167.65M2024: $426.86M2025: $348.90M$348.90M2008Net Income (USD)2025Fiscal YearNet IncomeChange YoY2025$348.90M-18.3%2024$426.86M+154.6%2023$167.65M+18.4%2022$141.56M+320.9%2021-$64.08M-107.5%2020$854.03M+3681.1%2019-$23.85M+69.1%2018-$77.21M+34.0%2017-$117.04M+81.4%2016-$630.21M-266.8%2015-$171.80M-28.2%2014-$133.97M+24.0%2013-$176.35M-54.2%2012-$114.35M-112.4%2011-$53.84M-126.2%2010$205.82M+42276.0%2009-$488.0K-101.6%2008$30.83M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share